Sunir Garg, MD, shares insights on new data on aflibercept 8 mg, faricimab, and the impact of social determinants of health, ...

One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...

QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery. Strategic partnership with the Research Institute of Molecular Patholog ...

Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

Boehringer Ingelheim had previously explored Ofev as a treatment for ... this is also a very important and valuable ...

With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

While at Boehringer Ingelheim, Dr. Mahaney’s teams were responsible for delivering drug candidates to the company’s global clinical portfolio, including several investigational assets in oncology, ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...